Identification of nucleolin as a cellular receptor for human respiratory syncytial virus

Nature Medicine

Volumn 17, Issue 9, 2011, Pages 1132-1135

  Tayyari, Farnoosh ^a   Marchant, David ^a   Moraes, Theo J ^b,c   Duan, Wenming ^b   Mastrangelo, Peter ^c   Hegele, Richard G ^b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; NUCLEOLIN; VIRUS FUSION PROTEIN; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING ASSAY; CELL SURFACE; FEMALE; HOST CELL; INSECT CELL; LEPIDOPTERA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RNA INTERFERENCE;

ANALYSIS OF VARIANCE; ANIMALS; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOPRECIPITATION; MICE; MICE, INBRED BALB C; PHOSPHOPROTEINS; RESPIRATORY SYNCYTIAL VIRUSES; RNA INTERFERENCE; RNA-BINDING PROTEINS; SPODOPTERA; TRANSFECTION; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

HEXAPODA; HUMAN RESPIRATORY SYNCYTIAL VIRUS; MUS; RICE STRIPE VIRUS; SPODOPTERA FRUGIPERDA;

EID: 80052499006     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2444     Document Type: Article

References (38)

1. Collins, P.L. & Graham, B.S. Viral and host factors in human respiratory syncytial virus pathogenesis. J. Virol. 82, 2040-2055 (2008). (Pubitemid 351293507)
2. Wu, H., Pfarr, D.S., Losonsky, G.A. & Kiener, P.A. Immunoprophylaxis of RSV infection: advancing from RSVIGIV to palivizumab and motavizumab. Curr. Top. Microbiol. Immunol. 317, 103-123 (2008).
3. Welliver, R.C. Pharmacotherapy of respiratory syncytial virus infection. Curr. Opin. Pharmacol. 10, 289-293 (2010).
4. Olszewska, W. & Openshaw, P. Emerging drugs for respiratory syncytial virus infection. Expert Opin. Emerg. Drugs 14, 207-217 (2009).
5. Magro, M., Andreu, D., GomezPuertas, P., Melero, J.A. & Palomo, C. Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein. J. Virol. 84, 7970-7982 (2010).
6. Adams, O. et al. Palivizumab-resistant human respiratory syncytial virus infection in infancy. Clin. Infect. Dis. 51, 185-188 (2010).
7. Lowry, F. FDA panel nixes licensing request for motavizumab. Medscape News (3 June 2010).
8. DeVincenzo, J. et al. A randomized, doubleblind, placebocontrolled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc. Natl. Acad. Sci. USA 107, 8800-8805 (2010).
9. Olszewska, W. et al. Antiviral and lung protective activity of a novel RSV fusion inhibitor in a mouse model. Eur. Respir. J. 38, 401-408 (2011).
10. Behera, A.K. et al. Blocking intercellular adhesion molecule1 on human epithelial cells decreases respiratory syncytial virus infection. Biochem. Biophys. Res. Commun. 280, 188-195 (2001). (Pubitemid 32917495)
11. Krusat, T. & Streckert, H.J. Heparindependent attachment of respiratory syncytial virus (RSV) to host cells. Arch. Virol. 142, 1247-1254 (1997). (Pubitemid 27266514)
12. Malhotra, R. et al. Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells. Microbes Infect. 5, 123-133 (2003). (Pubitemid 36316054)
13. Dimmock, N.J., Easton, A.J. & Leppard, K. Introduction to Modern Virology (Blackwell, Malden, Massachusetts, USA, 2007).
14. Techaarpornkul, S., Barretto, N. & Peeples, M.E. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J. Virol. 75, 6825-6834 (2001). (Pubitemid 32641568)
15. Hallak, L.K., Kwilas, S.A. & Peeples, M.E. Interaction between respiratory syncytial virus and glycosaminoglycans, including heparan sulfate. Methods Mol. Biol. 379, 15-34 (2007). (Pubitemid 350183350)
16. Techaarpornkul, S., Collins, P.L. & Peeples, M.E. Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Virology 294, 296-304 (2002). (Pubitemid 34920528)
17. Hallak, L.K., Spillmann, D., Collins, P.L. & Peeples, M.E. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 74, 10508-10513 (2000).
18. Collins, P.L. & Mottet, G. Posttranslational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus. J. Gen. Virol. 72, 3095-3101 (1991).
19. Crim, R.L., Audet, S.A., Feldman, S.A., Mostowski, H.S. & Beeler, J.A. Identification of linear heparinbinding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity. J. Virol. 81, 261-271 (2007). (Pubitemid 44975166)
20. Martínez, I. & Melero, J.A. Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans. J. Gen. Virol. 81, 2715-2722 (2000).
21. Cao, W. et al. Identification of alphadystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282, 2079-2081 (1998). (Pubitemid 29001263)
22. ReyesReyes, E.M. & Akiyama, S.K. Cellsurface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells. Exp. Cell Res. 314, 2212-2223 (2008).
23. Losfeld, M.E. et al. The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells. Exp. Cell Res. 315, 357-369 (2009).
24. Chen, X., Kube, D.M., Cooper, M.J. & Davis, P.B. Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA. Mol. Ther. 16, 333-342 (2008). (Pubitemid 351168043)
25. Taylor, G., Stott, E.J., Hughes, M. & Collins, A.P. Respiratory syncytial virus infection in mice. Infect. Immun. 43, 649-655 (1984). (Pubitemid 14176624)
26. Hibbs, A.R., MacDonald, G. & Garsha, K. Handbook of Biological Confocal Microscopy (Springer, New York, 2006).
27. Zhang, L., Peeples, M.E., Boucher, R.C., Collins, P.L. & Pickles, R.J. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol. 76, 5654-5666 (2002). (Pubitemid 34517916)
28. Srinivasakumar, N., Ogra, P.L. & Flanagan, T.D. Characteristics of fusion of respiratory syncytial virus with HEp2 cells as measured by R18 fluorescence dequenching assay. J. Virol. 65, 4063-4069 (1991).
29. Osiowy, C. & Anderson, R. Neutralization of respiratory syncytial virus after cell attachment. J. Virol. 69, 1271-1274 (1995).
30. Mikhaylova, L.M., Boutanaev, A.M. & Nurminsky, D.I. Transcriptional regulation by Modulo integrates meiosis and spermatid differentiation in male germ line. Proc. Natl. Acad. Sci. USA 103, 11975-11980 (2006). (Pubitemid 44215796)
31. Said, E.A. et al. Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin. FEBS J. 272, 4646-4659 (2005). (Pubitemid 41366988)
32. Bose, S., Basu, M. & Banerjee, A.K. Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J. Virol. 78, 8146-8158 (2004). (Pubitemid 38944299)
33. Levin Perlman, S., Jordan, M., Brossmer, R., Greengard, O. & Moscona, A. The use of a quantitative fusion assay to evaluate HNreceptor interaction for human parainfluenza virus type 3. Virology 265, 57-65 (1999). (Pubitemid 30012385)
34. Tufaro, F. Virus entry: two receptors are better than one. Trends Microbiol. 5, 257-258, discussion 258-259 (1997).
35. Hovanessian, A.G. et al. The cellsurfaceexpressed nucleolin is associated with the actin cytoskeleton. Exp. Cell Res. 261, 312-328 (2000). (Pubitemid 32010228)
36. Leistner, C.M., GruenBernhard, S. & Glebe, D. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell. Microbiol. 10, 122-133 (2008). (Pubitemid 350239061)
37. Nisole, S. et al. The antiHIV pentameric pseudopeptide HB19 binds the Cterminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. J. Biol. Chem. 277, 20877-20886 (2002). (Pubitemid 34967396)
38. Said, E.A. et al. The antiHIV cytokine midkine binds the cell surfaceexpressed nucleolin as a low affinity receptor. J. Biol. Chem. 277, 37492-37502 (2002).